Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Selin Somersan

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2016
N-methylation of a bactericidal compound as a resistance mechanism in Mycobacterium tuberculosisThulasi Warrier, Kanishk Kapilashrami, Argyrides Argyrou, et al.
Blood|June 11, 2026
Anticoagulation with mechanistically distinct FXI/FXIa antibodies amrecibart (REGN9933A2) and cenvacibart (REGN7508Cat)Dan Chalothorn, Aaron Paul Kithcart, Ethan Marin, et al.
Elife|April 30, 2024
Digital wearable insole-based identification of knee arthropathies and gait signatures using machine learningMatthew F Wipperman, Allen Z Lin, Kaitlyn M Gayvert, et al.
Neurobiology of Pain (Cambridge, Mass.)|December 15, 2023
Monoclonal antibodies against GFRα3 are efficacious against evoked hyperalgesic and allodynic responses in mouse join pain models but, one of these, REGN5069, was not effective against pain in a randomized, placebo-controlled clinical trial in patients with osteoarthritis painSelin Somersan-Karakaya, Kenneth C Turner, Luz Cortes-Burgos, et al.
ACS Infectious Diseases|June 12, 2019
Dual-Pharmacophore Pyrithione-Containing Cephalosporins Kill Both Replicating and Nonreplicating <i>Mycobacterium tuberculosis</i>Landys Lopez Quezada, Kelin Li, Stacey L McDonald, et al.
The Journal of Infectious Diseases|July 27, 2022
Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19Selin Somersan-Karakaya, Eleftherios Mylonakis, Vidya P Menon, et al.
Cell|June 23, 2021
The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studiesRichard Copin, Alina Baum, Elzbieta Wloga, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 26, 2022
Efficacy and Safety of Sarilumab in Hospitalized Patients With Coronavirus Disease 2019: A Randomized Clinical TrialSumathi Sivapalasingam, David J Lederer, Rafia Bhore, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2016
N-methylation of a bactericidal compound as a resistance mechanism in Mycobacterium tuberculosisThulasi Warrier, Kanishk Kapilashrami, Argyrides Argyrou, et al.
Blood|June 11, 2026
Anticoagulation with mechanistically distinct FXI/FXIa antibodies amrecibart (REGN9933A2) and cenvacibart (REGN7508Cat)Dan Chalothorn, Aaron Paul Kithcart, Ethan Marin, et al.
Elife|April 30, 2024
Digital wearable insole-based identification of knee arthropathies and gait signatures using machine learningMatthew F Wipperman, Allen Z Lin, Kaitlyn M Gayvert, et al.
Neurobiology of Pain (Cambridge, Mass.)|December 15, 2023
Monoclonal antibodies against GFRα3 are efficacious against evoked hyperalgesic and allodynic responses in mouse join pain models but, one of these, REGN5069, was not effective against pain in a randomized, placebo-controlled clinical trial in patients with osteoarthritis painSelin Somersan-Karakaya, Kenneth C Turner, Luz Cortes-Burgos, et al.
ACS Infectious Diseases|June 12, 2019
Dual-Pharmacophore Pyrithione-Containing Cephalosporins Kill Both Replicating and Nonreplicating <i>Mycobacterium tuberculosis</i>Landys Lopez Quezada, Kelin Li, Stacey L McDonald, et al.
The Journal of Infectious Diseases|July 27, 2022
Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19Selin Somersan-Karakaya, Eleftherios Mylonakis, Vidya P Menon, et al.
Cell|June 23, 2021
The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studiesRichard Copin, Alina Baum, Elzbieta Wloga, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 26, 2022
Efficacy and Safety of Sarilumab in Hospitalized Patients With Coronavirus Disease 2019: A Randomized Clinical TrialSumathi Sivapalasingam, David J Lederer, Rafia Bhore, et al.
Pageof 3